There are nearly 200 companies internationally working to develop a coronavirus vaccine. To get to the finish line, each will have to go through complicated approval processes.
Meet Dassault Systèmes, a French company with an Israeli subsidiary, that is capturing the clinical data in the right format and at the right time for dozens of these companies – including Moderna and Israel’s MIGAL, the Galilee Research Institute.
Full Story (Jerusalem Post)
